Please login to the form below
antimicrobial
This page shows the latest antimicrobial news and features for those working in and with pharma, biotech and healthcare.
Shionogi Europe and NHS England agree on antibiotic subscription model
The antibiotic Fetcroja, along with Zavicefta, will be made available as an option to help address antimicrobial resistance. ... continued ability to provide other healthcare – such as chemotherapy and surgical procedures – that might otherwise be
Latest news
-
NHS to offer two new treatments for drug-resistant superbugs as part of a new subscription-style payment plan
It is hoped that a fixed payment plan – independent of the amount of antibiotics used – will incentivise drug companies to increase their R&D efforts for antimicrobial treatments, in the race ... a recent BBC interview that only around 40 new
-
Longitude Prize in final stage of deciding recipients of £8m prize
The prize will be awarded to a team of innovators who develop a point-of-care diagnostic test that will help combat antimicrobial-resistant infections. ... The test will help to support treatment decisions, reduce overuse of antibiotics and confront the
-
The IMC unites health industry professionals to combat antibiotic resistant infections
critical viral and bacterial infection, with the aim of delivering effective antimicrobial stewardship (AMS). ... are appropriate, to public health and vaccination programmes in helping to avoid reliance on antimicrobials.
-
Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics
issue of antimicrobial resistance.
-
Roche buys GenMark for $1.8bn to bolster diagnostics portfolio
The rapid identification of bloodstream infections and the detection of antimicrobial resistance genes are more essential than ever for hospitals and their patients,” he added.
More from news
Approximately 52 fully matching, plus 74 partially matching documents found.
Latest Intelligence
-
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
However, we cannot be complacent when it comes to another rising infectious threat: antimicrobial resistance, or AMR.
-
Rebranding in an evolving world
in recent years, despite the ever- increasing health burden of antimicrobial resistance globally.
-
Rethinking our approach to infectious disease preparedness
Antimicrobial resistance. There is a second pandemic that we have to deal with – the rising tide of antimicrobial resistance, where bacteria are becoming resistant to the antibiotics we routinely use to
-
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19. ... The World Health Organization (WHO) states that antimicrobial resistance (AMR) is a global concern.
-
The global antibiotic crisis: a 2020 perspective
In the forward of the 2019 CDC report on the threat posed by antimicrobial resistance he said simply: ‘We need stop referring to a coming post-antibiotic era – it’s already ... The plan is the latest step towards the government’s broader 20-year
More from intelligence
Approximately 8 fully matching, plus 15 partially matching documents found.
Latest appointments
-
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
resistance, which is a part of the broader issue of antimicrobial resistance.
-
IFPMA names new communications director
and to enable government to meet ambitious goals such as universal health coverage, global health security and continued innovation in areas of high unmet health needs such as antimicrobial resistance.
-
Destiny Pharma appoints new CEO
Destiny Pharma has appointed Neil Clark as CEO as the Brighton, UK-based firm plans a phase IIb trial for its lead antimicrobial candidate.
-
New health ministers and re-appointments after reshuffle
Ellison, who reprises her role as the secretary for public health that she has held since 2013, also has a wide remit that includes pharma as will have responsibility for: antimicrobial
-
Xellia forms scientific advisory board
drugs to help tackle the global crisis of antimicrobial resistance.”. ... Antimicrobial resistance is a huge area of unmet medical need and one of the greatest threats to human health.
More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
For years, concerns have been mounting about a problem that has the potential to set our health services back 100 years: the rise of antimicrobial resistance. ... WHO. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Published
-
Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics
Other recent progress includes NovaBiotics’ novel antimicrobial-immunomodulator, Nylexa, which is now set to enter phase 3 clinical trials in the UK for COVID-19 and non-COVID pneumonia (in hospitalised ... NP432, derived from NovaBiotics’
-
Antibiotic resistance: The silent pandemic
Up to 2 billion people, mainly in low- and middle-income countries, lack access to antimicrobials. ... Available at: https://www.healtheuropa.eu/antimicrobial-resistance/88272/. Accessed November 2019. World Health Organization. WHO global strategy for
-
Mobilising the public to combat the antimicrobial resistance crisis
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Her illness is due to antimicrobial resistance (AMR) and it is not as rare as you might think.
-
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating ... Antimicrobial resistance claims 5,
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- A new era for UK-Japanese scientific research relations
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Sanofi Global Health unveils new nonprofit Impact brand
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
PMHub
Apex.co.uk Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
